摘要
Background:Inflammation and renal interstitial fibrosis are the main pathological features of hypertensive nephropathy. Interferon regulatory factor 4 (IRF-4) has an important role in the pathogenesis of inflammatory and fibrotic diseases. However, its role in hypertension-induced renal inflammation and fibrosis remains unexplored.Method and results:We showed that deoxycorticosterone acetate (DOCA)-salt resulted in an elevation of blood pressure and that there was no difference between wild-type and IRF-4 knockout mice. IRF-4(-/-) mice presented less severe renal dysfunction, albuminuria, and fibrotic response after DOCA-salt stress compared with wild-type mice. Loss of IRF-4 inhibited extracellular matrix protein deposition and suppressed fibroblasts activation in the kidneys of mice subjected to DOCA-salt treatment. IRF-4 disruption impaired bone marrow-derived fibroblasts activation and macrophages to myofibroblasts transition in the kidneys in response to DOCA-salt treatment. IRF-4 deletion impeded the infiltration of inflammatory cells and decreased the production of proinflammatory molecules in injured kidneys. IRF-4 deficiency activated phosphatase and tensin homolog and weakened phosphoinositide-3 kinase/AKT signaling pathway in vivo or in vitro. In cultured monocytes, TGF & beta;1 also induced expression of fibronectin and & alpha;-smooth muscle actin and stimulated the transition of macrophages to myofibroblasts, which was blocked in the absence of IRF-4. Finally, macrophages depletion blunted macrophages to myofibroblasts transition, inhibited myofibroblasts accumulation, and ameliorated kidney injury and fibrosis.Conclusion:Collectively, IRF-4 plays a critical role in the pathogenesis of kidney inflammation and fibrosis in DOCA-salt hypertension.
学科与关键词
- IRF-4 deficiency reduces inflammation and kidney fibrosis after folic acid-induced acute kidney injuryChen, Meixin; Wen, Xianjie; Gao, Ying; Liu, Benquan; Zhong, Chaoqun; Nie, Jiayi; Liang, Hua*International Immunopharmacology, 2021, 100: 108142.被引 12
- Jmjd3/IRF4 axis aggravates myeloid fibroblast activation and m2 macrophage to myofibroblast transition in renal fibrosisLiang, Hua; Liu, Benquan; Gao, Ying; Nie, Jiayi; Feng, Shuyun; Yu, Wenqiang*; Wen, Shihong; Su, Xi*Frontiers in Immunology, 2022, 13: 978262.被引 8
- TGF-β1 peptide-based inhibitor P144 ameliorates renal fibrosis after ischemia-reperfusion injury by modulating alternatively activated macrophagesLi, Delun; Zhang, Jian; Yuan, Siyu; Wang, Chao; Chang, Jiakai; Tong, Yan; Liu, Ran; Sang, Tian; Li, Lili; Li, Jijun; Ouyang, Qing*; Chen, Xiangmei*Cell Proliferation, 2022, 55(10): e13299.被引 6
